About
Andrew Brackin is a Partner at Gradient, where he invests in vertical AI, healthcare, and application-layer companies. Before moving into investing, he co-founded Vial, a tech-enabled clinical trial platform that raised more than $100M, and served as the founding Head of Growth at Newfront, a commercial insurance brokerage acquired by WTW for $1.3B in 2025. He started his career at Jobr, a mobile job search app acquired by Monster in 2016. He was selected as a 2013 Thiel Fellow, one of 20 people worldwide awarded $100,000 to pursue entrepreneurship instead of attending college. Originally from London, he now lives in San Francisco.
Invests in
AI & Machine LearningDigital HealthHealthtech
Beyond investing
- Founded
- Co-founded Vial, a tech-enabled clinical trial platform that has raised over $100M.
- Awards
- Was named a 2013 Thiel Fellow, one of 20 recipients worldwide selected to receive $100,000 to pursue entrepreneurship instead of college.
- Hobbies
- Loves politics and live music.
- More
- Originally from London.
From Andrew's own website β common ground for a warm intro.
Experience
- GradientPartnercurrent2024 β presentSan Francisco Bay Area
- HostieBoard Membercurrent2025 β present
- Enzo HealthBoard Membercurrent2024 β present
- Vera HealthInvestorcurrent2024 β present
- VialCo-Founder2020 β 2023San Francisco, CA
- NewfrontHead of Growth (Acquired by WTW)2018 β 2020San Francisco, CA
- Jobr for BusinessFounding Team (Acquired By Monster)2014 β 2018San Francisco, CA
- The Thiel FoundationFellow2013 β 2015San Francisco Bay Area
Skills & more
+12 more
Digital StrategyDigital MarketingSocial NetworkingWeb DesignNew MediaMobile DevicesSocial Media MarketingE-commerceEmail MarketingAdvertisingProduct ManagementA/B TestingFrom Andrew's professional profile.
Deals Β· 3
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Led
Enzo Health
Investor
Sources: the firm's website Β· the investor's own website.
Colleagues at Gradient Ventures
Network9
Investors connected to Andrew in public investor directories β a warm-intro map.
Frequently asked questions
- Who is Andrew Brackin?
- Andrew Brackin is a Partner at Gradient, where he invests in vertical AI, healthcare, and application-layer companies. Before moving into investing, he co-founded Vial, a tech-enabled clinical trial platform that raised more than $100M, and served as the founding Head of Growth at Newfront, a commercial insurance brokerage acquired by WTW for $1.3B in 2025. He started his career at Jobr, a mobile job search app acquired by Monster in 2016. He was selected as a 2013 Thiel Fellow, one of 20 people worldwide awarded $100,000 to pursue entrepreneurship instead of attending college. Originally from London, he now lives in San Francisco.
- Where does Andrew Brackin work?
- Andrew Brackin is Partner at Gradient Ventures.
- What does Andrew Brackin invest in?
- Andrew Brackin invests in AI & Machine Learning, Digital Health, Healthtech.
- What companies has Andrew Brackin invested in?
- Investments tracked here include Enzo Health, Forge, Paladin, Vera Health, Enzo Health, Forge, Vera Health.
- Where did Andrew Brackin go to school?
- Andrew Brackin studied at Thiel Fellowship.
- What awards has Andrew Brackin received?
- Was named a 2013 Thiel Fellow, one of 20 recipients worldwide selected to receive $100,000 to pursue entrepreneurship instead of college.
- Does Andrew Brackin lead rounds?
- Yes β Andrew Brackin has led 4 tracked investments.
Same school
Shared employers
Also worked at Hostie1
Also worked at Vera Health2
Also worked at Vial3
Also worked at Newfront10
+ 4 more